Boehringer Ingelheim To Acquire Actimis Pharmaceuticals
Jun 19th 2008Drug InformationAllergies
Boehringer Ingelheim GmbH announced an agreement to acquire Actimis Pharmaceuticals, Inc., a privately owned biotech company based in San Diego. The acquisition will occur through a structured buyout in which Boehringer Ingelheim will acquire shares of Actimis depending on the achievement of several successive milestones with Actimis’ leading asthma compound AP768.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
